- Home
- CMCT vs NCNA Comparison
CMCT vs NCNA Comparison
Compare CMCT & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMCT
- NCNA
- Stock Information
- Founded
- CMCT 1993
- NCNA 1997
- Country
- CMCT United States
- NCNA United Kingdom
- Employees
- CMCT N/A
- NCNA N/A
- Industry
- CMCT Real Estate Investment Trusts
- NCNA Biotechnology: Pharmaceutical Preparations
- Sector
- CMCT Real Estate
- NCNA Health Care
- Exchange
- CMCT Nasdaq
- NCNA Nasdaq
- Market Cap
- CMCT 4.0M
- NCNA 4.5M
- IPO Year
- CMCT N/A
- NCNA 2017
- Fundamental
- Price
- CMCT $6.59
- NCNA $0.04
- Analyst Decision
- CMCT
- NCNA Buy
- Analyst Count
- CMCT 0
- NCNA 2
- Target Price
- CMCT N/A
- NCNA $25.00
- AVG Volume (30 Days)
- CMCT 104.5K
- NCNA 20.6M
- Earning Date
- CMCT 05-09-2025
- NCNA 05-19-2025
- Dividend Yield
- CMCT 7.65%
- NCNA N/A
- EPS Growth
- CMCT N/A
- NCNA N/A
- EPS
- CMCT N/A
- NCNA N/A
- Revenue
- CMCT $123,706,000.00
- NCNA N/A
- Revenue This Year
- CMCT N/A
- NCNA N/A
- Revenue Next Year
- CMCT N/A
- NCNA N/A
- P/E Ratio
- CMCT N/A
- NCNA N/A
- Revenue Growth
- CMCT 4.10
- NCNA N/A
- 52 Week Low
- CMCT $2.75
- NCNA $0.10
- 52 Week High
- CMCT $76.96
- NCNA $10.79
- Technical
- Relative Strength Index (RSI)
- CMCT 50.83
- NCNA 34.61
- Support Level
- CMCT $6.01
- NCNA $0.41
- Resistance Level
- CMCT $6.73
- NCNA $0.42
- Average True Range (ATR)
- CMCT 0.84
- NCNA 0.13
- MACD
- CMCT 0.37
- NCNA -0.06
- Stochastic Oscillator
- CMCT 66.76
- NCNA 0.21
About CMCT Creative Media & Community Trust Corporation
Creative Media & Community Trust Corp is formed to invest in, own, and operate Class A and creative office investments in improving urban communities throughout the United States. It operates through segments such as office, hotel and multifamily properties and lending. The Office segment includes rental of office space and other tenant services, including tenant reimbursements, parking, and storage space rental. The Hotel segment relates to operations of hotel properties whereas, the lending segment refers to income from the yield and other related fee income earned on its loans receivable. The lending segment includes income recognized from the sale of government guaranteed portion of loans receivable, income from the yield on its loans receivable and other related fee income earned.
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.